Click Therapeutics
New York
About Click Therapeutics
Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $1.0B
- Funding stage: Late Stage Venture
- Last round: Series C (Mar 2025)
- Website: clicktherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical Device, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/click-therapeutics-112091 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.